RNIB welcomes Humira recommendation

Sight charity RNIB has welcomed NHS England’s decision to recommend the use of Humira (adalimumab) in children with severe refractory uveitis.

Earlier this year, NHS England had refused to fund anti-TNF treatments, including Humira and Remicade, but RNIB campaigned against the decision.

Dr Maria Dawson, RNIB eye health campaigns officer, said: ‘The decision will come as a huge relief to parents worried about their children not responding to standard treatments and losing further sight.’